Navigation Links
NUVO Surgical Light - Single Light Head Monitor Ready

ProductsNUVO Surgical Light - Single Light Head Monitor Ready
Company NUVO Inc.
Item NUVO Surgical Light - Single Light Head Monitor Ready
Features 
  • On/Off, Pattern Size adjustment and Light Intensity can all be adjusted by the surgeon from within the sterile field.
  • 137,000 Lux (12,700 Footcandles) light intensity from a single 180 Watt bulb.
  • Back-up bulb that illuminates within milliseconds when the primary bulb fails.
  • Spare bulbs are conveniently located in the wall control housing for easy access.
  • Sealed light head combined with ultra cool operation at only 3.71 W/cm2/Fc
  • Color correct light optimized at 4,300°K to ensure accurate patient assessment.
  • Superior shadow control -- the light head will tolerate as much as 70% of the emitted light being blocked before a noticeable change in pattern intensity is witnessed.
  • Drift-free counterbalance arms that are free to rotate continuously at every joint.
  • Pre-wired for Composite, S-video or RGBS signals. The monitor hubs are ready to add Monitors at a moments notice.
  • Every Light Mount is pre-equipped to accept two Flat Screen Monitors.
  • Each Light Mount is designed to rotate continuously to provide the user with the maximum freedom of movement when positioning the monitor.
  • All necessary wiring is pre-installed at the time of Light installation in order to minimize disruption when adding the Monitors at a later date.
Description With the increase in Endoscopic cases, it is extremely popular to combine a Flat Screen LCD Monitor with the Surgical Light. This combination affords the surgeon optimal viewing of the monitor without having to adopt an uncomfortable pose. The Single Light System has the capability of including the NUVO Monitoring System. As such the light can be purchased separately and the Monitor(s) purchased and added at a later date.
Info NUVO Inc.
Customer Service: (800) 663-1152
Web site: http://www.nuvosurgical.com

Related medicine products :

1. No.12 Surgical Blade
2. No. SM68 Surgical Blade
3. Surgiscribe Surgical Marking Pens
4. Surgical Markers
5. TLS Surgical Markers
6. SQUEEZE-MARK Surgical Markers
7. Ultra MD40 Super Pulse CO2 Surgical Laser
8. Ultra MD 60 Super Pulse CO2 Surgical Laser
9. Ultra MD 80 Super Pulse CO2 Surgical Laser
10. Reliance Mobile Surgical Stretcher
11. Ocular Posner Diagnostic And Surgical Gonioprism
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products:
(Date:8/3/2015)... ... August 04, 2015 , ... Approved provider ... line up of live courses for the month of August. , Physical therapy ... individually or by purchasing a Physical Therapy Flex package. Flex packages allow therapists ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sutter Health’s California Pacific Medical ... (COO) at CPMC. Hamila will start in her role effective immediately and will have ... has worked at CPMC and Sutter Health for about 15 years, including the past ...
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data ... IT to create efficiencies in healthcare information exchange, announced the release of its findings ... and Human Services (HHS) Secretary, WEDI shared survey results and recommendations ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... ruled in favor of the firm’s client Rebecca Hamsher, deciding that in accordance ... must reimburse benefits for Hamsher’s residential treatment for bulimia, depression and other mental ...
(Date:8/3/2015)... ... August 03, 2015 , ... A recent ... an overwhelming number of Hispanics believe people can positively affect their diabetes, few ... participants queried said making diet changes was important. Far fewer participants mentioned the ...
Breaking Medicine News(10 mins):Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 3Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4
... The National Patient Safety Foundation,(NPSF) today announced that ... leading health care solutions providers to work,alongside the ... their families -- all with the single convergent ... http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO ), "We are excited to be ...
... of Pennsylvania School of Medicine can now explain how ... in the blood stream at any one time. These ... fight infections. , "There is a steady state number ... says senior author Michael P. Cancro, PhD, Professor of ...
... with inflammatory diseases such as rheumatoid arthritis now have ... biologic disease-modifying antirheumatic drugs (DMARDs). These drugs, derived by ... of the disease rather than simply treating the symptoms. ... because a one month,s supply may cost 100 times ...
... Henri de Toulouse-Lautrec suffered, is a genetic disease characterized ... window into how joints are destroyed by arthritis. It ... cathepsin K which hampers osteoclasts (the cells that break ... poor bone resorption and dense, brittle bones. , ...
... Co-Pays, HOUSTON, Nov. 4 US Oncology today ... pharmacy, has,exceeded the $10 million mark in assisting more ... Care Advantage in August 2006., "It was important ... patient access to oral chemotherapies by easing the financial,burdens ...
... MYL ),today announced that its subsidiary Mylan ... and Drug Administration (FDA) for its,Abbreviated New Drug ... and 750 mg. Levetiracetam Tablets are the generic ... Mylan,s Vice Chairman and CEO, commented: "We are,extremely ...
Cached Medicine News:Health News:AmerisourceBergen Joins National Patient Safety Foundation Corporate Council 2Health News:Penn scientists show how body determines optimal amount of germ-fighting B cells 2Health News:Medicaid policies vary widely for rheumatoid arthritis drugs 2Health News:Genetic disorder sheds light on enzyme's role in bone metabolism 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 3Health News:Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately 2
(Date:8/3/2015)... Aug. 3, 2015 VWR (NASDAQ: ... and solutions, announces the redesign of its global website, ... When visiting the new site, guests will enjoy enhanced ... and vivid images.  Each country site now includes: ... Z product menu; and , the ability to search ...
(Date:8/3/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced ... Investor Conference Call and webcast at 4:30 p.m., Eastern time, ... cover an update on Merrimack,s progress as well as ... release detailing the information to be discussed on the ... 10. Investors and the general public are invited to ...
(Date:8/3/2015)... and FLORHAM PARK, N.J. , Aug. ... naldemedine met its primary and secondary endpoints in a ... opioid-induced constipation (OIC) in adult patients with chronic non-cancer ... receptor antagonist (PAMORA). This is the third Phase III ... secondary endpoints. Study results showed that a ...
Breaking Medicine Technology:VWR's New Website Redesign Provides Improved Functionality for Customers 2Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4